Protective Effects of Vitamin C on Cisplatin-Induced Renal Damage: A Light and Electron Microscopic Study

REFERENCES

• Antunes LM, Darin JD, Bianchi MD. Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats. Pharmacol. Res. 2001; 43: 145–150
   PubMed Web of Science ®Google Scholar
• Meyer KB, Madias NE. Cisplatin nephrotoxicity. Miner. Electrolyte. Metab. 1994; 20: 201–213
   PubMedGoogle Scholar
• Antunes LM, Darin JD, Bianchi MD. Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: A dose-dependent study. Pharmacol. Res. 2000; 41: 405–411
   PubMed Web of Science ®Google Scholar
• Vickers AEM, Rose K, Fisher R, Saulnier M, Sahota P, Bentley P. Kidney slices of human and rat to charactarize cisplatin-induced injury on cellular pathways and morphology. Toxicol Pathol. 2004; 32: 577–590
   PubMed Web of Science ®Google Scholar
• Durak I, Ozbek H, Karaayvaz M, Ozturk HS. Cisplatin induced acute renal failure by impairing antioxidant system in guinea pigs: Effects of antioxidant supplementation on the cisplatin nephrotoxicity. Drug Chem Toxicol. 2002; 25: 1–8
   PubMed Web of Science ®Google Scholar
• Appenroth D, Frob S, Kertsen L, Splinter FK, Winnefeld K. Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch. Toxicol. 1997; 71: 677–683
   PubMed Web of Science ®Google Scholar
• Saleh S, el-Demerdash E. Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: Role of nitric oxide. Basic Clin Pharmacol Toxicol. 2005; 97: 91–97
   PubMed Web of Science ®Google Scholar
• Blisard KS, Harrington DA. Toxicity of cis-diamminedichloroplatinum (II) (Cisplatin) in the frog. Rana pipiens. J. Comp. Pathol. 1990; 103: 387–398
   Google Scholar
• el-Shazly MO, Afify MM, el-Dieb MK. Histopathological study into side-effect toxicity of some drugs used in treatment of cancer. Arch Exp Veterinarmed. 1989; 43: 319–326
   PubMedGoogle Scholar
• Zhang J, Lindup E. Cisplatin nephrotoxicity: Decrease in mitochondrial protein sulphydryl concentration and calcium uptake by mitochondria from rat renal cortical slices. Biochem. Pharmacol. 1994; 47: 1127–1135
   PubMed Web of Science ®Google Scholar
• Mistry P, Merazga Y, Spargo DJ, Riley PA, McBbrien DCH. The effects of cisplatin on the concentration of protein thiols and glutathione in the rat kidney. Cancer Chemother Pharmacol. 1991; 28: 277–282
   PubMed Web of Science ®Google Scholar
• Sadzuka Y, Shoji T, Takino Y. Effect of cisplatin on the activities of enzymes which protect against lipid peroxidation. Biochem. Pharmacol. 1992; 43: 1872–1875
   PubMed Web of Science ®Google Scholar
• Hannemann J, Baumann K. Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: Different effects of antioxidants and radical scavengers. Toxicology. 1988; 51: 119–132
   PubMed Web of Science ®Google Scholar
• Sadzuka Y, Shoji T, Takino Y. Mechanism of the increase in lipid peroxide induced by cisplatin in the kidneys of rats. Toxicol. Lett. 1992; 62: 293–300
   PubMed Web of Science ®Google Scholar
• Sugihara K, Nakano S, Koda M, Tanaka K, Fukuishi N, Gemba M. Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues. Jpn J Pharmacol. 1987; 43: 247–252
   PubMedGoogle Scholar
• Fukushi N, Gemba M. Use of cultured renal epithelial cells for the study of cisplatin toxicity. Jpn J Pharmacol. 1989; 50: 247–249
   Google Scholar
• Nishikawa M, Nagatomi H, Nishijima M, et al. Targeting superoxide dismutase to renal proximal tubule cells inhibits nephrotoxicity of cisplatin and increases the survival of cancer-bearing mice. Cancer Lett. 2001; 171: 133–138
   PubMed Web of Science ®Google Scholar
• Sueishi K, Mishima K, Makino K, et al. Protection by a radical scavenger edaravone against cisplatin-induced nephrotoxicity in rats. Eur. J. Pharmacol. 2002; 451: 203–208
   PubMed Web of Science ®Google Scholar
• Bompart G, Orfila C. Cisplatin nephrotoxicity in lead-pretreated rats: Enzymatic and morphological studies. Toxicol Lett. 1990; 50: 237–247
   Google Scholar
• Atessahin A, Yilmaz S, Karahan I, Ceribasi AO, Karaoglu A. Effects of lycopene againts cisplatin-induced nephrotoxicity and oxitadive stress in rats. Toxicology. 2005; 212: 116–123
   PubMed Web of Science ®Google Scholar
• Olivero OA, Semino C, Kassim A, Lopez-Larraza DM, Pirier MC. Preferential binding of cisplatin to mitochondrial DNA of chinese hamster ovary cells. Mutat. Res. 1995; 346: 221–230
   Google Scholar
• Cilenti L, Kyriazis GA, Soundarapandian MM, et al. Omi/HtrA2 protease mediates cisplatin-induced cell death in renal cells. Am. J. Physiol. Renal Physiol. 2005; 288: 371–379
   PubMed Web of Science ®Google Scholar
• Tsao CS. An overview of ascorbic acid chemistry and biochemistry. Vitamin C in Health and Disease., L Packer, J Fuchs. Marcel Dekker, New York 1997; 25–58
   Google Scholar
• Frei B, Stocker R, England L, Ames BN. Ascorbate: The most effective antioxidant in human blood plasma. Adv. Exp. Med Biol. 1990; 264: 155–163
   PubMedGoogle Scholar
• Halliwell B, C vitamin. Antioxidant or pro-oxidant in vivo?. Free Radical Res. 1996; 25: 439–454
   PubMed Web of Science ®Google Scholar
• Carr A, Frei B. Does vitamin C act as a pro-oxidant under physiological conditions?. FASEB J. 1999; 13: 1007–1023
   PubMed Web of Science ®Google Scholar
• Padh H. Vitamin C: Newer insight into its biochemical functions. Nutr Rev. 1991; 49: 65–70
   PubMed Web of Science ®Google Scholar
• Guinee DG, van Zee B, Houghton DC. Clinically silent progressive renal tubulointerstitial disease during cisplatin chemotherapy. Cancer. 1993; 71: 4050–4054
   PubMedGoogle Scholar
• Brady HR, Kone BC, Stromski ME, Zeidel ML, Giebisch G, Gullans SR. Mitochondrial injury: An early event in cisplatin toxicity to renal proximal tubules. Am J Physiol. 1990; 258: 1181–1187
   Google Scholar
• Kawai Y, Taniuchi S, Okahara S, Nakamura M, Gemba M. Relationship between cisplatin or nedaplatin-induced nephrotoxicity and renal accumulation. Biol. Pharm. Bull. 2005; 28: 1385–1388
   PubMed Web of Science ®Google Scholar
• Orfila C, Bompart G, Lepert JC, Suc JM, Girolami JP. Renal immunolocalization of kallikrein in cisplatin nephrotoxicity in rats. Histochem J. 1993; 25: 772–777
   Google Scholar
• Daugaard G, Abildgaard U. Cisplatin nephrotoxicity. Cancer Cemother. Pharmacol. 1989; 25: 1–9
   PubMed Web of Science ®Google Scholar
• Kanaka C, Oetliker OH, Bianchetti MG. Chronic cisplatin tubulopahty in humans and animals: Clear-cut discrepant findings. Nephron. 1991; 59: 693
   Google Scholar
• Choie DD, Longnecker DS, del Campo AA. Acute and chronic nephropathy in rats. Lab. Invest. 1981; 44: 397–402
   PubMed Web of Science ®Google Scholar
• Mohan IK, Khan M, Shobha JC, et al. Protection against cisplatin-induced nephrotoxicity by spirulina in rats. Cancer Chemother. Pharmacol. 2006; 58: 802–808
   PubMed Web of Science ®Google Scholar
• Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner NW. Mechanism of cisplatinum nephrotoxicity II: Morphologic observations. J. Pharmacol. Exp. Ther. 1980; 7: 551–556
   Google Scholar
• Racusen LC, Solez R. Nephrotoxic tubular and interstitial lesions: Morphology and classification. Toxicol Pathol. 1986; 14: 45–49
   PubMedGoogle Scholar
• Herak-Kramberger CM, Sabolic I. The integrity of renal cortical brush-border and basolateral membrane vesicles is damaged in vitro by nephrotoxic heavy metals. Toxicology. 2001; 156: 139–147
   Google Scholar
• Gemba M, Fukuishi N. Amelioration by ascorbic acid of cisplatin-induced injury in cultured renal. Contrib Nephrol. 1991; 95: 138–142
   PubMedGoogle Scholar
• Sener G, Satiroglu H, Kabasakal L, et al. The protective effect of melatonin on cisplatin nephrotoxicity. Fundam Clin Pharmacol. 2000; 14: 553–560
   PubMed Web of Science ®Google Scholar
• Naziroglu M, Karaoglu A, Aksoy AO. Selenium and high dose vitamin E administration protects cisplatin-induced oxidative damage to renal, liver and lens tissues in rats. Toxicology. 2004; 195: 221–230
   PubMed Web of Science ®Google Scholar
• Bogin E, Marom M, Levi Y. Changes in serum, liver and kidneys of cisplatin-trated rats: Effects of antioxidants. Eur J Clin Chem Clin Biochem. 1994; 32: 843–851
   PubMedGoogle Scholar
• Panayiotidis M, Collins AR. Ex vivo assesment of lymphocyte antioxidant status using the commet assay. Free Radical Res. 1997; 27: 533–537
   PubMed Web of Science ®Google Scholar
• Blasiak J, Kowalik J. Protective action of vitamin C against DNA damage induced by selenium-cisplatin conjugate. Acta Biochim Pol. 2001; 48: 233–240
   PubMed Web of Science ®Google Scholar
• Antunes LMG, Araújo MCP, Darin JDC, Bianchi MLP. Effects of the antioxidants curcumin and vitamin C on cisplatin-induced clastogenesis in Wistar rat bone marrow cells. Mutat. Res. 2000; 465: 131–137
   PubMed Web of Science ®Google Scholar
• Jordan P, Carmo-Fonseca M. Molecular mechanisms involved in cisplatin cytotoxicity. Cell Mol Life Sci. 2000; 57: 1229–1235
   PubMed Web of Science ®Google Scholar
• Block G, Henson DE, Levine M, vitamin C. A new look. Ann Intern Med. 1991; 114: 909–910
   PubMedGoogle Scholar
• Vissers MCM, Lee WG, Hampton MB. Regulation of apoptosis by vitamin C. J. Biol. Chem. 2001; 276: 46835–46840
   PubMed Web of Science ®Google Scholar